These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 23523416)
1. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis. Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416 [TBL] [Abstract][Full Text] [Related]
2. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Broomé U; Löfberg R; Lundqvist K; Veress B Dis Colon Rectum; 1995 Dec; 38(12):1301-5. PubMed ID: 7497843 [TBL] [Abstract][Full Text] [Related]
3. Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Brentnall TA; Haggitt RC; Rabinovitch PS; Kimmey MB; Bronner MP; Levine DS; Kowdley KV; Stevens AC; Crispin DA; Emond M; Rubin CE Gastroenterology; 1996 Feb; 110(2):331-8. PubMed ID: 8566577 [TBL] [Abstract][Full Text] [Related]
4. The Development of Serrated Epithelial Change in Ulcerative Colitis is not Significantly Associated With Increased Histologic Inflammation. Bahceci D; Wang D; Lauwers GY; Choi WT Am J Surg Pathol; 2024 Jun; 48(6):719-725. PubMed ID: 38584461 [TBL] [Abstract][Full Text] [Related]
6. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. D'Haens GR; Lashner BA; Hanauer SB Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083 [TBL] [Abstract][Full Text] [Related]
7. Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease. Silvain C; Zeevi A; Saidman S; Duquesnoy RJ; Van Thiel DH Hepatogastroenterology; 1995 Jul; 42(3):250-8. PubMed ID: 7590574 [TBL] [Abstract][Full Text] [Related]
8. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases. Florin TH; Pandeya N; Radford-Smith GL Gut; 2004 Jul; 53(7):973-9. PubMed ID: 15194646 [TBL] [Abstract][Full Text] [Related]
9. Increased Active Inflammation in the Colon is Not a Reliable Predictor of an Elevated Risk of Dysplasia in Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis. Zhang R; Wang D; Lauwers GY; Choi WT Am J Surg Pathol; 2024 May; ():. PubMed ID: 38809303 [TBL] [Abstract][Full Text] [Related]
10. Dysplasia and cancer in ulcerative colitis: a soluble problem? Riddell RH Scand J Gastroenterol Suppl; 1984; 104():137-49. PubMed ID: 6597546 [TBL] [Abstract][Full Text] [Related]
11. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia. Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381 [TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy? Broomé U; Lindberg G; Löfberg R Gastroenterology; 1992 Jun; 102(6):1877-80. PubMed ID: 1587406 [TBL] [Abstract][Full Text] [Related]
15. Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Woolrich AJ; DaSilva MD; Korelitz BI Gastroenterology; 1992 Aug; 103(2):431-8. PubMed ID: 1634062 [TBL] [Abstract][Full Text] [Related]
16. Quality of Surveillance Impacts the Colitis-Associated Advanced Neoplasia Risk: A Multicenter Case-Control Study. Te Groen M; Derks M; den Broeder N; Peters C; Dijkstra G; de Vries A; Romkens T; Horjus C; de Boer N; de Jong M; Nagtegaal I; Derikx L; Hoentjen F Clin Gastroenterol Hepatol; 2024 Feb; 22(2):357-367.e5. PubMed ID: 36572110 [TBL] [Abstract][Full Text] [Related]
17. Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience. Wang MH; Mousa OY; Friton JJ; Raffals LE; Leighton JA; Pasha SF; Picco MF; Cushing KC; Monroe K; Nix BD; Newberry RD; Faubion WA Inflamm Bowel Dis; 2020 Apr; 26(5):774-779. PubMed ID: 31626701 [TBL] [Abstract][Full Text] [Related]
18. Sigmoidoscopy and biopsy in surveillance for cancer in ulcerative colitis. Fochios SE; Sommers SC; Korelitz BI J Clin Gastroenterol; 1986 Jun; 8(3 Pt 1):249-54. PubMed ID: 3734356 [TBL] [Abstract][Full Text] [Related]
19. Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme. Leidenius M; Kellokumpu I; Husa A; Riihelä M; Sipponen P Gut; 1991 Dec; 32(12):1521-5. PubMed ID: 1773959 [TBL] [Abstract][Full Text] [Related]
20. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways. Quraishi MN; Acharjee A; Beggs AD; Horniblow R; Tselepis C; Gkoutos G; Ghosh S; Rossiter AE; Loman N; van Schaik W; Withers D; Walters JRF; Hirschfield GM; Iqbal TH J Crohns Colitis; 2020 Jul; 14(7):935-947. PubMed ID: 32016358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]